Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Guidance on when Traditional Budgeting is most appropriate, including typical use cases and factors to consider for your finances.
21,043 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A year-opening move from VOO to RSP drew attention as market leadership changed in 2026. Early results show RSP ahead...
BlackRock's tokenized BUIDL fund will publish continuous on-chain attestations to back holdings, valuation, and custo...
Energy leaders convene amid a tightening mix of growth and risk. AI-driven demand and geopolitical tensions push pric...
Apple and Intel are reportedly exploring a U.S.-based chip supply and manufacturing pact. The talks, if they advance,...
Trump signals possible U.S. ground action against Mexican cartels, sending ripples through defense stocks and supply ...
Investors weigh income reliability and risk as markets shift. A $1.5 million portfolio that pays roughly $83,400 annu...
Qualcomm exploded higher, gaining about 70% in a single month as it pivots toward AI data-center demand. Investors ar...
Bitcoin holds a narrow range around the high $70Ks to near $80K as investors await a decisive breakout. Analysts warn...
Moderna shares rose about 6% early trading after better-than-expected Q1 results and renewed vaccine interest. Pfizer...
Circle stock surged after first-quarter results beat expectations and a fresh Arc funding round. This Morning Minute ...
Teresa Palacios Smith leads a broad push to embed inclusion into everyday operations at HomeServices of America, tur...